Concentra Group HoldingsCON
Recorded

Concentra Group Holdings 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration47 minParticipants14

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good morning, and thank you for joining us today for the Concentra Group Holdings Parent Inc. earnings conference call to discuss the third quarter 2026 results. Speaking today are the company's executive chairman, Keith Newton, the company's president and chief executive officer, Matt DiCanio, and the company's executive vice president and chief financial officer, Tanner Newton. Management will give you an overview and then open the call for questions. Before we get started, we would like to remind you that this conference call may contain forward-looking statements regarding future events or the future financial performance of the company, including without limitation, statements regarding operating results, growth opportunities, and other statements that refer to Concentra's current plans, expectations, strategies, intentions, and beliefs.

Operator

You are hereby cautioned that these forward-looking statements may be affected by the important factors, among others, set forth in Concentra's earnings release and that reports that are filed or furnished to the SEC. Consequently, actual operations and results may differ materially from those discussed in the forward-looking statements. These forward-looking statements are based on the information available to management of Concentra today, and the company assumes no obligation to update these statements as circumstances change. Additionally, during today's call, we may reference measures such as Adjusted EBITDA, Adjusted EBITDA margin, and free cash flow, which are non-GAAP financial measures. The definitions of Adjusted EBITDA, Adjusted EBITDA margin, and free cash flow, and the tables reconciling those metrics to the corresponding GAAP measures are provided in the earnings release. At this time, I'll turn the conference over to Mr. Keith Newton, Mr. Matt DiCanio, and Mr. Tanner Newton.

Keith NewtonExecutive Chairman

Thank you, and good morning. This is our first earnings call following our leadership transition, and I'd like to begin by congratulating Matt on his assumption of the chief executive officer role and Tanner on his assumption of the chief financial officer role, effective as of November 1st. These appointments reflect a thoughtful succession process and the strength of the leadership team we have built over many years. Concentra enters this next chapter from a position of considerable strength. We have a differentiated market position, a proven strategy, strong operational execution, and a talented, very experienced team serving our patients, employer customers, and partners every day. I am confident that Matt, Tanner, and the broader leadership team are exceptionally well-positioned to build on the momentum we've established and continue to create long-term value for our stakeholders. While my role has changed, my commitment to Concentra remains the same.

Keith NewtonExecutive Chairman

As executive chairman, I'll continue to partner very closely with Matt, the board, and the leadership team to support our strategic priorities and ensure a seamless and successful transition. I'm very excited about the opportunities ahead and the future of the company. With that, I'll turn the call over to Matt.

Matt DiCanioPresident and CEO

Thank you, Keith, and good morning. I appreciate your leadership and look forward to continuing our partnership in your role as Executive Chairman. I also want to welcome Tanner to his first earnings call as Chief Financial Officer. We had a great third quarter with strong visit volume, higher revenue per visit, and disciplined cost management driving significant earnings growth. Let's jump into some of the highlights. Total revenue increased 8.6% year-over-year to $622.1 million. Net income was $67.8 million, up 36% from a year ago, and Adjusted EBITDA was $140.2 million, up 17.9% from a year ago. Tanner will walk through the financial details, but I want to spend a few minutes on what we saw across the business and where we are focused. Total occupational health center patient visits increased 4.9% to an average of more than 58,000 visits per day in the third quarter.

Matt DiCanioPresident and CEO

Our workers' compensation visits per day increased 4.2%, and employer services visits per day increased 5.8% relative to prior year. We believe this performance reflects a combination of favorable labor market conditions in many of the blue-collar sectors we serve and continued market share gains. Growth was broad-based across all six of our regions and most end markets. Recent activity in our employer services business remains particularly encouraging, with strong increases in hiring-related services such as drug screens and physicals across transportation and logistics, manufacturing, construction-oriented customers, and other industries as well. The activity we are seeing among customers in these sectors continues to indicate healthy workforce demand. We believe our ongoing investments in sales execution, account management, and technology continue to strengthen our competitive position and support market share gains. Customer retention remains at multi-year highs, while year-to-date new business activity is tracking ahead of 2025 levels.

Matt DiCanioPresident and CEO

Turning to our occupational health center rate, revenue per visit increased 3.3% year-over-year in the third quarter. This growth was driven by a 3.5% increase in workers' compensation and a 4.0% increase in employer services revenue per visit. Employer services revenue per visit was slightly elevated this quarter, in part due to a shift in the mix with services comprising a larger percentage of higher revenue per visit physicals relative to drug screens. During the third quarter, we acquired four medical centers in Minnesota. We also opened three de novo centers in Kansas City, Missouri, Boise, Idaho, and Daytona Beach, Florida, with the latter two representing new markets for Concentra. Following quarter end, we opened two additional centers near Pensacola, Florida, and Washington, D.C. We expect to open one more center before the end of this year.

Matt DiCanioPresident and CEO

In total, completed acquisitions and de novo development are expected to add 15 new centers during 2026. We are currently anticipating low double-digit de novo openings in 2027. Our M&A pipeline remains strong, with multiple bolt-on transactions progressing well. We see attractive opportunities to continue expanding the business through both acquisitions and de novo development, and we will remain disciplined in evaluating returns and executing on those opportunities. Within the onsite business, fundamentals remain strong, supported by employers' continued focus on managing their rising healthcare costs, a growing sales pipeline, and strong operational execution as we capture the benefits of the Pivot integration. I will now turn the call over to Tanner to review our financial results in more detail.

Tanner NewtonEVP and CFO

Thank you, Matt, and good morning. I am pleased to join you in my new role and look forward to continuing to work with our leadership team and the investment community. I will begin with our consolidated results, then review operating segment performance, expenses, cash flow, and the balance sheet. Total company revenue was $622.1 million in Q3 2026 compared to $572.8 million in Q3 of the prior year, representing 8.6% growth year-over-year. We saw a slight acceleration in year-over-year organic revenue growth compared to Q2, which grew at 8%. Net income attributable to the company in Q3 2026 was $65.9 million, or $0.52 per share, compared to $48.3 million and $0.38 per share respectively in Q3 2025.

Tanner NewtonEVP and CFO

Adjusted net income attributable to the company in Q3 2026 was $66.1 million, and adjusted earnings per share was $0.52, compared with $49.9 million and $0.39 per share respectively in Q3 2025, reflecting growth of 33.3% in adjusted earnings per share year-over-year. Adjusted EBITDA increased 17.9% to $140.2 million, and adjusted EBITDA margin expanded 178 basis points to 22.5%. Sequentially, relative to Q2, margin was affected by one additional expense day in Q3 compared with the second quarter. More broadly, the year-over-year improvement reflects strong volume and rate growth, disciplined execution, and operating efficiencies across the business. Next, breaking down revenue by segment. Total occupational health center revenue increased 8.3% year-over-year to $569.7 million. Workers' compensation revenue increased 7.9% to $370.5 million, while employer services revenue increased 10% to $190.5 million. On-site revenue increased 10% year-over-year to $38.4 million.

Tanner NewtonEVP and CFO

Organic growth moderated versus Q2 as Pivot entered the organic calculation following the acquisition anniversary, with Pivot's relatively modest year-over-year growth diluting stronger growth in the core business. Finally, other businesses, which include telemedicine, pharmacy operations, and other occupational health-related services, generated revenue of $14.1 million, an increase of 18.4% year-over-year. Moving on to expenses. Cost of services was $426.7 million, or 68.6% of revenue in Q3 2026, an improvement from 70.8% of revenue for the same quarter of the prior year. The drivers were consistent with the first half of the year, with strong flow-through from visit and rate growth, together with favorable staffing efficiencies across our centers. Our total general and administrative expenses were $60.9 million, or 9.8% of revenue in Q3 2026, compared to 9.2% of revenue in the same quarter of the prior year.

Tanner NewtonEVP and CFO

Excluding items that are added back for the purposes of calculating Adjusted EBITDA, including equity compensation expense, one-time Select separation costs, and M&A transaction costs, G&A expense was $56.4 million for the quarter, or 9.1% of revenue, compared to 8.5% of revenue in the same quarter of the prior year. Turning to cash flow. In Q3, we generated $51.9 million of operating cash flow compared to $60.6 million in the third quarter of 2025. The year-over-year decrease was driven primarily by working capital timing and higher cash tax payments following the roll-off of certain tax benefits associated with the OBBBA that we received in the prior year period. Excluding these factors, the underlying cash-generating capacity of the business remains strong and consistent with our expectations.

Tanner NewtonEVP and CFO

Investing activities used a net $25.9 million of cash in the third quarter, which includes both acquisition capital related to our Minnesota deal that closed in the quarter and net inflows from the sale of a previously owned building. Free cash flow, or cash flow from operations less cash flow used in investing activity, excluding business combinations, totaled $32.2 million, a decrease from prior year third quarter free cash flow of $40.2 million. The year-over-year decrease was primarily due to the aforementioned lower cash flow from operations in Q3 2026. Finally, financing activities used $98.2 million of cash during the quarter. We repurchased 1 million shares for $34.65 million and returned an additional $8 million to shareholders through dividends. At September 30, 2026, approximately $19 million remained under the board's original $100 million repurchase authorization.

Tanner NewtonEVP and CFO

Subsequent to quarter end, the board authorized a new $250 million share repurchase program with no expiration date. The authorization provides additional flexibility to return capital while continuing to invest in organic growth, acquisitions and de novos, and debt reduction. The board also declared a quarterly cash dividend of $0.0625 per share payable on or about December 4, 2026, to shareholders of record as of November 19, 2026. During the quarter, we repaid $52.4 million on our term loan B, comprised of both mandatory amortization and a $50 million discretionary prepayment. We ended the quarter with a total debt balance of $1.52 billion and a cash balance of $85.8 million. Our net leverage ratio per our credit agreement at the end of September was 2.90 times.

Tanner NewtonEVP and CFO

We were also pleased to receive a ratings upgrade from S&P Global in August, with our corporate rating improving from BB- to BB. In mid-October, Moody's also revised its outlook from stable to positive. Now, I'll turn it back over to Matt to close us out with some comments on separation activity, as well as our updated guidance.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day